Challenges in the development and establishment of exosome-based drug delivery systems

被引:218
作者
Wang, Jin [1 ]
Chen, Derek [1 ]
Ho, Emmanuel A. [1 ,2 ]
机构
[1] Univ Waterloo, Sch Pharm, Kitchener, ON, Canada
[2] Waterloo Inst Nanotechnol, Waterloo, ON, Canada
基金
加拿大健康研究院;
关键词
Exosomes; Extracellular vesicles; Nanoparticles/nanomedicines; Drug delivery; NANOPARTICLE TRACKING ANALYSIS; MILK-DERIVED EXOSOMES; EXTRACELLULAR VESICLES; CELLULAR UPTAKE; IN-VITRO; CULTURE SUPERNATANT; CEREBRAL-ISCHEMIA; FLOW-CYTOMETRY; HUMAN SALIVA; PACLITAXEL;
D O I
10.1016/j.jconrel.2020.10.020
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Exosomes are extracellular vesicles released from cells and are characterized by a lipid bilayer membrane encapsulating a variety of biological molecules such as nucleic acids or proteins within the lumen or the lipid-bilayer. Under physiological environments, exosomes mediate cell-to-cell communication and cargo transport. Therefore, exosomes have been explored as drug delivery vehicles for improving therapeutic outcomes. Although recent studies have demonstrated promising advances with exosome-based drug delivery systems, several challenges severely hinder further development of exosomes for clinical applications. This review summarizes and emphasizes some of the technical challenges related to the isolation, characterization, and stability testing of exosomes. More importantly, challenges related specifically to the application of exosomes for drug delivery such as cell-uptake, drug loading, drug release, and in vivo distribution will be examined in this article.
引用
收藏
页码:894 / 906
页数:13
相关论文
共 50 条
  • [41] Exosome-based immunotherapy
    Chaput, N
    Taïeb, J
    Schartz, NEC
    André, F
    Angevin, E
    Zitvogel, L
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (03) : 234 - 239
  • [42] Exosomes as Anticancer Drug Delivery Vehicles: Prospects and Challenges
    Zhang, Yubo
    Li, Jian
    Gao, Wei
    Xie, Na
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2022, 27 (10):
  • [43] Exosome-based immunotherapy
    Nathalie Chaput
    Julien Taïeb
    Noël E. C. Schartz
    Fabrice André
    Eric Angevin
    Laurence Zitvogel
    Cancer Immunology, Immunotherapy, 2004, 53 : 234 - 239
  • [44] Exosome-based intercellular communication in female reproductive microenvironments
    Ranjbaran, Ali
    Latifi, Zeinab
    Nejabati, Hamid Reza
    Abroon, Sina
    Mihanfar, Aynaz
    Sadigh, Aydin Raei
    Fattahi, Amir
    Nouri, Mohammad
    Raffel, Nathalie
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) : 19212 - 19222
  • [45] Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells
    Balaraman, Ashok Kumar
    Babu, M. Arockia
    Afzal, Muhammad
    Sanghvi, Gaurav
    Rekha, M. M.
    Gupta, Sofia
    Rana, Mohit
    Ali, Haider
    Goyal, Kavita
    Subramaniyan, Vetriselvan
    Wong, Ling Shing
    Kumarasamy, Vinoth
    REGENERATIVE THERAPY, 2025, 28 : 558 - 572
  • [46] Exosome-based immunotherapy as an innovative therapeutic approach in melanoma
    Babaei, Shabnam
    Fadaee, Manouchehr
    Abbasi-kenarsari, Hajar
    Shanehbandi, Dariush
    Kazemi, Tohid
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [47] Exosome-based antisense locked nucleic acid delivery for inhibition of type II collagen degradation in chondrocyte
    Jeong, Kyeongsoo
    Jeong, Seunga
    Kim, Jeong Ah
    Rhee, Won Jong
    JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY, 2019, 74 : 126 - 135
  • [48] Exosome-based nanoparticles and cancer immunotherapy
    Ye, Jiarong
    Li, Danni
    Jie, Yiting
    Luo, Hongliang
    Zhang, Wenjun
    Qiu, Cheng
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 179
  • [49] Exosome-based approaches in the management of Alzheimer?s disease
    Kandimalla, Raghuram
    Saeed, Mohd
    Tyagi, Neetu
    Gupta, Ramesh C.
    Aqil, Farrukh
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2023, 144
  • [50] Exosome-based immunotherapy: a promising approach for cancer treatment
    Xu, Zhijie
    Zeng, Shuangshuang
    Gong, Zhicheng
    Yan, Yuanliang
    MOLECULAR CANCER, 2020, 19 (01)